Outcome | Cases: n/(%) ** | OR* | 95% CI* |
---|---|---|---|
Diabetes | Â | Â | Â |
   Multiple Supp users | 8/(2.9) | 0.27 | 0.12–0.59 |
   Single Supp users | 23/(11.1) | 1.11 | 0.74–1.67 |
   No Supp users | 70/(8.5) | 1.00 |  |
Coronary Heart Disease | Â | Â | Â |
   Multiple Supp users | 14/(5.0) | 0.48 | 0.22–1.09 |
   Single Supp users | 17/(7.1) | 1.08 | 0.52–2.25 |
   No Supp users | 47/(5.6) | 1.00 |  |
Heart Attack | Â | Â | Â |
   Multiple Supp users | 7/(2.5) | 0.51 | 0.18–1.41 |
   Single Supp users | 16/(7.6) | 1.76 | 0.90–3.42 |
   No Supp users | 44/(4.4) | 1.00 |  |
Angina | Â | Â | Â |
   Multiple Supp users | 6/(2.2) | 0.41 | 0.14–1.18 |
   Single Supp users | 12/(6.8) | 1.71 | 0.82–3.59 |
   No Supp users | 35/(4.7) | 1.00 |  |
Congestive Heart Failure | Â | Â | Â |
   Multiple Supp users | 4/(1.4) | 0.73 | 0.18–2.95 |
   Single Supp users | 9/(2.8) | 0.88 | 0.26–2.97 |
   No Supp users | 31/(3.5) | 1.00 |  |
Stroke | Â | Â | Â |
   Multiple Supp users | 5/(1.8) | 1.42 | 0.39–5.17 |
   Single Supp users | 6/(2.6) | 1.26 | 0.34–4.67 |
   No Supp users | 29/(2.5) | 1.00 |  |
Arthritis | Â | Â | Â |
   Multiple Supp users | 88/(31.7) | 1.00 | 0.69–1.46 |
   Single Supp users | 71/(31.8) | 1.23 | 0.77–1.98 |
   No Supp users | 189/(26.7) | 1.00 |  |
Emphysema | Â | Â | Â |
   Multiple Supp users | 3/(1.1) | 0.55 | 0.09–3.41 |
   Single Supp users | 4/(1.8) | 0.73 | 0.32–1.64 |
   No Supp users | 23/(2.3) | 1.00 |  |
Health Status†|  |  |  |
   Multiple Supp users | 44/(15.8) | 0.26 | 0.17–0.41 |
   Single Supp users | 86/(44.4) | 0.75 | 0.45–1.23 |
   No Supp users | 302/(50.9) | 1.00 |  |